Cancer Cause and Prevention Research in Ohio
Cancer Cause and Prevention Research (93.393) awarded $105 million to recipients in Ohio in 72 grants from fiscal 2021 to 2025, 2.9% of the program's national total. The Ohio State University received the most, $59.6 million.
- Awarded in Ohio$105 million
- Awards72
- Share of the program2.9%
- Rank among states10th of 48
- National total$3.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 30 | $14.4 million |
| FY 2022 | 38 | $18.5 million |
| FY 2023 | 46 | $24.9 million |
| FY 2024 | 43 | $22.0 million |
| FY 2025 | 41 | $24.8 million |
Recipients in Ohio
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| The Ohio State University | Colleges and universities | 38 | $59.6 million |
| Case Western Reserve University | Colleges and universities | 15 | $22.5 million |
| Cleveland Clinic Lerner College of Medicine of Case Western Reserve University | Colleges and universities | 7 | $10.6 million |
| Research Institute at Nationwide Children's Hospital | Nonprofits | 3 | $5.9 million |
| Childrens Hospital Medical Center | Nonprofits | 5 | $2.6 million |
| Opsiclear LLC | Small businesses | 2 | $2.4 million |
| University of Toledo | Colleges and universities | 1 | $699,249 |
| Battelle Memorial Institute | Nonprofits | 1 | $409,936 |
Open opportunities under this program
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 60 on the program page
Questions people ask
How much Cancer Cause and Prevention Research money goes to Ohio?
$105 million from fiscal 2021 to 2025, across 72 awards. Ohio ranks 10th of 48 states and territories for this program.
Who receives Cancer Cause and Prevention Research money in Ohio?
The largest recipient is The Ohio State University, with $59.6 million in 38 awards. Next are Case Western Reserve University and Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.
Can organizations in Ohio apply now?
Yes, 60 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Cause and Prevention Research in other states
Other large programs in Ohio
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Temporary Assistance for Needy Families
- Title I Grants to Local Educational Agencies
- Children's Health Insurance Program
- Child Care and Development Block Grant
- Special Education Grants to States
- Head Start